163 related articles for article (PubMed ID: 38782946)
1. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome.
He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z
Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946
[TBL] [Abstract][Full Text] [Related]
2. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
[TBL] [Abstract][Full Text] [Related]
3. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice.
Wang L; Ding J; Zhu C; Guo B; Yang W; He W; Li X; Wang Y; Li W; Wang F; Sun T
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34676876
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M
Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
[TBL] [Abstract][Full Text] [Related]
6. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
[TBL] [Abstract][Full Text] [Related]
7. The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy.
Tang LQ; Wang W; Tang QF; Wang LL
BMC Cardiovasc Disord; 2024 Jan; 24(1):18. PubMed ID: 38172711
[TBL] [Abstract][Full Text] [Related]
8. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
He Q; Li Z; Meng C; Wu J; Zhao Y; Zhao J
Cells; 2019 Aug; 8(8):. PubMed ID: 31416289
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
10. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
[TBL] [Abstract][Full Text] [Related]
11. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation.
Tang X; Pan L; Zhao S; Dai F; Chao M; Jiang H; Li X; Lin Z; Huang Z; Meng G; Wang C; Chen C; Liu J; Wang X; Ferro A; Wang H; Chen H; Gao Y; Lu Q; Xie L; Han Y; Ji Y
Circulation; 2020 Mar; 141(12):984-1000. PubMed ID: 31902237
[TBL] [Abstract][Full Text] [Related]
12. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
Liu H; You L; Wu J; Zhao M; Guo R; Zhang H; Su R; Mao Q; Deng D; Hao Y
J Leukoc Biol; 2020 Jul; 108(1):253-266. PubMed ID: 32272506
[TBL] [Abstract][Full Text] [Related]
13. RyR2 Stabilizer Attenuates Cardiac Hypertrophy by Downregulating TNF-α/NF-κB/NLRP3 Signaling Pathway through Inhibiting Calcineurin.
Gao Y; Li S; Liu X; Si D; Chen W; Yang F; Sun H; Yang P
J Cardiovasc Transl Res; 2024 Jun; 17(3):481-495. PubMed ID: 38652413
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
15. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z
Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417
[TBL] [Abstract][Full Text] [Related]
16. Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus.
Ye JS; Chen L; Lu YY; Lei SQ; Peng M; Xia ZY
Oxid Med Cell Longev; 2019; 2019():8639618. PubMed ID: 30918581
[TBL] [Abstract][Full Text] [Related]
17. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
18. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
19. Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation.
Cao S; Shrestha S; Li J; Yu X; Chen J; Yan F; Ying G; Gu C; Wang L; Chen G
Sci Rep; 2017 May; 7(1):2417. PubMed ID: 28546552
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
